BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8917199)

  • 1. Automatic preparation of radiopharmacokinetic data for in vivo estimation of receptor biochemistry.
    Xu JC; Vera DR; Stadalnik RC
    J Nucl Med; 1996 Nov; 37(11):1896-902. PubMed ID: 8917199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of a receptor-binding radiopharmacokinetic model.
    Vera DR; Stadalnik RC; Metz CE; Pimstone NR
    J Nucl Med; 1996 Jan; 37(1):160-4. PubMed ID: 8543988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
    Kudo M; Vera DR; Trudeau WL; Stadalnik RC
    J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asialoglycoprotein receptor and hepatic blood flow using technetium-99m-DTPA-galactosyl human serum albumin.
    Miki K; Kubota K; Kokudo N; Inoue Y; Bandai Y; Makuuchi M
    J Nucl Med; 1997 Nov; 38(11):1798-807. PubMed ID: 9374359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local identifiability of a receptor-binding radiopharmacokinetic system having measured parameters of known uncertainty.
    Vera DR; Scheibe PO; Banin Y; Stadalnik RC
    IEEE Trans Biomed Eng; 1994 Sep; 41(9):891-7. PubMed ID: 7959816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Galactosyl neoglycoalbumin:preparation and studies of its binding with hepatic special receptor].
    Pang Q; Yang L; Zhong Y; Guan C; Zhao Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):368-71. PubMed ID: 1814813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.
    Vera DR; Stadalnik RC; Trudeau WL; Scheibe PO; Krohn KA
    J Nucl Med; 1991 Jun; 32(6):1169-76. PubMed ID: 2045930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of hepatic asialoglycoprotein receptors after major hepatic resection.
    Kokudo N; Vera DR; Koizumi M; Seki M; Sato T; Stadalnik RC; Takahashi T
    J Nucl Med; 1999 Jan; 40(1):137-41. PubMed ID: 9935069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.
    Pimstone NR; Stadalnik RC; Vera DR; Hutak DP; Trudeau WL
    Hepatology; 1994 Oct; 20(4 Pt 1):917-23. PubMed ID: 7927233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo quantification of asialoglycoprotein receptor.
    Kudo M; Vera DR; Stadalnik RC
    Methods Enzymol; 1994; 247():373-82. PubMed ID: 7898365
    [No Abstract]   [Full Text] [Related]  

  • 11. Portal-Systemic shunts reduce asialoglycoprotein receptor density in rats.
    Colquhoun SD; Connelly CA; Vera DR
    J Nucl Med; 2001 Jan; 42(1):110-6. PubMed ID: 11197958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
    Vera DR; Woodle ES; Stadalnik RC
    J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage.
    Kudo M; Todo A; Ikekubo K; Hino M
    Am J Gastroenterol; 1992 Jul; 87(7):865-70. PubMed ID: 1615940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system.
    Vera DR; Scheibe PO; Krohn KA; Trudeau WL; Stadalnik RC
    IEEE Trans Biomed Eng; 1992 Apr; 39(4):356-67. PubMed ID: 1592401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tc-NGA imaging in liver transplantation: preclinical studies.
    Woodle ES; Vera DR; Stadalnik RC; Ward RE
    Surgery; 1987 Jul; 102(1):55-62. PubMed ID: 3296267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
    Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
    Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The preparation of 99mTc-NGA instant lyophilized kit for hepatic imaging].
    Guan C; Chen Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):429-32. PubMed ID: 8150449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.
    Kudo M; Vera DR; Trudeau WL; Stadalnik RC
    Int J Rad Appl Instrum B; 1991; 18(7):663-6. PubMed ID: 1787074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The preparation of hepatic receptor imaging agent 99mTc-DTPA-NGA].
    Li Y; Guan C; Wang Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):54-8. PubMed ID: 9208621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.
    Kurtaran A; Li SR; Raderer M; Leimer M; Müller C; Pidlich J; Neuhold N; Hübsch P; Angelberger P; Scheithauer W
    J Nucl Med; 1995 Oct; 36(10):1875-81. PubMed ID: 7562058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.